This site is intended for health professionals only
Friday 22 June 2018

Kathy Oxtoby

Articles by this author

Thu 21 June
Thu 21 June
Targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors
Thu 21 June
Thu 21 June
Global pharmaceutical company to discontinue a late-stage trial assessing the efficacy of an experimental therapy in reducing chronic cluster headaches.
Wed 20 June
Wed 20 June
Idorsia launches PRECISION – Phase 3 study with aprocitentan for resistant hypertension management in adults
Thu 14 June
Thu 14 June
International team of researchers have developed new DNA test to identify men at greatest risk of prostate cancer
Thu 14 June
Thu 14 June
Cancer fighting effects of aspirin revealed in bowel tumour study
Wed 6 June
Wed 6 June
Evidence on whether cabozantinib increases the overall length of time people live is “less certain” says the National Institute for Health and Care Excellence
Wed 6 June
Wed 6 June
First monoclonal antibody therapy for prevention of migraine
Fri 1 June
Fri 1 June
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumors
Fri 1 June
Fri 1 June
Health and Social Care Committee identifies key areas associated with childhood obesity, which demand urgent attention from government
Fri 1 June
Fri 1 June
Based on a recent planned review, the Data Monitoring Committee (DMC) recommends termination of Phase Ib/II study of daratumumab plus atezolizumab (anti PD-L1 antibody) in patients with previously treated non-small cell lung cancer
Thu 24 May
Thu 24 May
Children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones, paediatric researchers have found
Thu 24 May
Thu 24 May
European programme to help people access edaravone for ALS treatment established by pharmaceutical companies
Thu 24 May
Thu 24 May
Juluca (dolutegravir/rilpivirine), has been endorsed as the first 2-drug regimen, once-daily, single-pill for the treatment of HIV
Fri 18 May
Fri 18 May
Nearly half of women with HIV lack help to manage menopause, a new study finds
Thu 17 May
Thu 17 May
NICE U-turn recommends Biogen’s Avonex® (interferon beta-1a) for relapsing-remitting multiple sclerosis
Fri 11 May
Fri 11 May
Scottish Medicines Consortium gives positive decision for Stivarga® (regorafenib) for treatment of adults with hepatocellular carcinoma who have been previously treated with sorafenib
Fri 11 May
Fri 11 May
NHS failure to send invitations may have resulted in women having their lives shortened, according to estimates
Thu 10 May
Thu 10 May
Blood cancer drugs brentuximab, vedotin, midostaurin will now be available on the NHS giving hundreds of individuals more therapy choices
Thu 3 May
Thu 3 May
Study finds the addition of this medicine to lenalidomide and dexamethasone (KRd) can extend the life of people with incurable blood cancer
Thu 3 May
Thu 3 May
Leading cancer charities launch awards to help advance understanding of the disease and develop new treatments to improve survival